Valuation: AstraZeneca PLC

Capitalization 282B 242B 222B 211B 388B 27,023B 394B 2,659B 1,029B 12,828B 1,057B 1,034B 44,693B P/E ratio 2026 *
22.9x
P/E ratio 2027 * 20.1x
Enterprise value 301B 259B 237B 226B 414B 28,868B 421B 2,840B 1,099B 13,704B 1,129B 1,105B 47,743B EV / Sales 2026 *
4.75x
EV / Sales 2027 * 4.37x
Free-Float
96.63%
Yield 2026 *
1.84%
Yield 2027 * 1.94%
1 day-0.79%
1 week+2.16%
Current month-2.27%
1 month-7.68%
3 months-9.83%
6 months+0.74%
Current year-1.15%
1 week 13,218
Extreme 13218
13,900
1 month 12,356
Extreme 12356
15,118
Current year 12,356
Extreme 12356
15,732
1 year 10,103
Extreme 10103
15,732
3 years 9,461
Extreme 9461
15,732
5 years 7,842.82
Extreme 7842.8225
15,732
10 years 3,680
Extreme 3680
15,732
Manager TitleAgeSince
Chief Executive Officer 66 30/09/2012
Director of Finance/CFO 52 31/07/2021
Compliance Officer - 31/12/2022
Director TitleAgeSince
Director/Board Member 70 05/04/1999
Director/Board Member 66 30/09/2012
Director/Board Member 65 26/04/2017
Change 5d. change 1-year change 3-years change Capi.($)
-0.79%+2.16%+34.41%+13.60% 282B
-0.00%+5.95%+37.04%+131.28% 896B
-1.77%+2.44%+51.53%+42.09% 546B
-0.18%+4.39%+15.80%+43.52% 372B
+0.88%+2.38%+25.60%+13.56% 328B
-0.10%+2.93%+29.16%+26.15% 283B
-1.79%0.00%+48.90%-4.29% 275B
+0.91%+3.07%-31.12%-48.50% 206B
-2.22%-1.62%+20.10%+39.73% 176B
-1.88%-1.33%+29.14%+65.32% 161B
Average -0.69%+2.07%+26.06%+32.25% 352.42B
Weighted average by Cap. -0.57%+3.17%+30.87%+50.73%

Financials

2026 *2027 *
Net sales 63.32B 54.49B 49.82B 47.54B 87.14B 6,075B 88.58B 598B 231B 2,884B 238B 233B 10,048B 67.11B 57.75B 52.8B 50.38B 92.35B 6,439B 93.88B 633B 245B 3,056B 252B 246B 10,649B
Net income 12.46B 10.72B 9.8B 9.35B 17.15B 1,195B 17.43B 118B 45.51B 567B 46.76B 45.76B 1,977B 14.1B 12.13B 11.09B 10.58B 19.4B 1,353B 19.72B 133B 51.5B 642B 52.91B 51.78B 2,237B
Net Debt 19.23B 16.54B 15.13B 14.43B 26.46B 1,845B 26.9B 181B 70.23B 876B 72.15B 70.61B 3,051B 11.57B 9.96B 9.11B 8.69B 15.93B 1,110B 16.19B 109B 42.27B 527B 43.43B 42.5B 1,836B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
15/05/26 13,632.00 p -0.79% 1,865,072
14/05/26 13,740.00 p -0.19% 696,665
13/05/26 13,766.00 p +0.13% 1,571,789
12/05/26 13,748.00 p +1.82% 3,257,867
11/05/26 13,502.00 p +1.18% 3,377,059
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
181.60USD
Average target price
221.77USD
Spread / Average Target
+22.12%

Quarterly revenue - Rate of surprise